Functionally impaired TR mutants are present in thyroid papillary cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 3, 2002, Pages 1120-1128

  Puzianowska Kuznicka, Monika ^a,b   Krystyniak, Agnieszka ^a   Madej, Agnieszka ^a   Cheng, Sheue Yann ^c   Nauman, Janusz ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN TRALPHA; PROTEIN TRBETA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR BIOLOGY; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID PAPILLARY CARCINOMA;

EID: 0036964285     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.3.8296     Document Type: Article

References (52)

1. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM, Lubensky I, Duan DR, Florence C, Pozzatti R, Walther MM, Bander NH, Grossman HB, Rauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM 1994 Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 7:85-90
2. Bishop DT 1999 BRCA1 and BRCA2 and breast cancer incidence: a review. Ann Oncol 10(Suppl 6):113-119
3. Damm K 1993 ErbA: tumor suppressor turned oncogene? FASEB J 7:904-909
4. Wolffe AP, Collingwood TN, Li Q, Yee J, Urnov F, Shi YB 2000 Thyroid hormone receptor, v-ErbA, and chromatin. Vitam Horm 58:449-492
5. Ciana P, Braliou GG, Demay FG, von Lindern M, Barettino D, Beug H, Stunnenberg HG 1998 Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. EMBO J 17:7382-7394
6. Thormeyer D, Bahniamad A 1999 The v-erbA oncogene. Int J Mol Med 4:351-358
7. Barlow C, Meister B, Lardelli M, Lendahl U, Vennstrom B 1994 Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA. EMBO J 13:4241-4250
8. Puzianowska-Kuznicka M, Damjanovski S, Shi YB 1997 Both thyroid hormone and 9-cis retinoic acid receptors are required to efficiently mediate the effects of thyroid hormone on embryonic development and specific gene regulation in Xenopus laevis. Mol Cell Biol 17:4738-4749
9. Zhang XK, Hoffmann B, Tran VB, Graupner G, Pfahl M 1992 Retinoid X receptor in an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355:441-446
10. Forman BM, Casanova J, Raaka BM, Ghysdael J, Samuels HH 1992 Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to response elements as monomers, homodimers or heterodimers. Mol Endocrinol 6:429-442
11. Yen PM, Spanjaard RA, Sugawara A, Darling DS, Nguyen VP, Chin WW 1993 Orientation and spacing of half-sites differentially affect T3-receptor (TR) monomer, homodimer and heterodimer binding to thyroid hormone response elements (TREs). Endocr J 1:461-466
12. Yen PM, Chin WW 1994 New advances in understanding the molecular mechanisms of thyroid hormone action. Trends Endocrinol Metab 5:65-72
13. Schrader M, Carlberg C 1994 Thyroid hormone and retinoic acid receptors form heterodimers with retinoid X receptors on direct repeats, palindromes and inverted palindromes. DNA Cell Biol 13:333-341
14. Chen JD, Evans RM 1995 A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
15. Horlein AJ, Naar AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Soderstrom M, Glass CK, Rosenfeld MG 1995 Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
16. Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
17. Lin K, Chen SI, Zhu XG, Shieh H, McPhie P, Cheng S 1997 The gene regulating activity of thyroid hormone nuclear receptors is modulated by cell-type specific factors. Biochem Biophys Res Commun 238:280-284
18. Dobrovic A, Houle B, Belouchi A, Bradley WE 1988 erbA-related sequence coding for DNA-binding hormone receptor localized to chromosome 3p21-3p25 and deleted in small cell lung carcinoma. Cancer Res 48:682-685
19. Drabkin H, Kao FT, Hartz J, Hart I, Gazdar A, Weinberger C, Evans R, Gerber M 1988 Localization of human ERBA2 to the 3p22-3p24.1 region of chromosome 3 and variable deletion in small cell lung cancer. Proc Natl Acad Sci USA 85:9258-9262
20. Leduc F, Brauch H, Hajj C, Dobrovic A, Kaye F, Gazdar A, Harbour JW, Pettengill OS, Sorenson GD, van den Berg A, Kok K, Campling B, Paquin F, Bradley WEC, Zbar B, Minna J, Buys C, Ayoub J 1989 Loss of heterozygosity in a gene coding for a thyroid hormone receptor in lung cancers. Am J Hum Genet 44:282-287
21. Sisley K, Curtis D, Rennie IG, Rees RC 1993 Loss of heterozygosity of the thyroid hormone receptor β in posterior uveal melanoma. Melanoma Res 3:457-461
22. Foster K, Crossey PA, Carins P, Hetherington W, Richards FM, Jones MH, Bentley E, Affara NA, Ferguson-Smith MA, Maher ER 1994 Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22. Br J Cancer 69:230-234
23. Gosden JR, Middleton PG, Rout D, Angelis C 1986 Chromosomal localization of the human oncogene ERBA2. Cytogenet Cell Genet 43:150-153
24. Futreal PA, Soderkvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, Wiseman RW 1992 Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 52:2624-2627
25. Lin KH, Shieh HY, Chen SL, Hsu HC 1999 Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol Carcinog 26:53-61
26. 3, and retinoid signalling. Endocrinology 135:2375-2385
27. Gittoes NJ, McCabe CJ, Verhaeg J, Sheppard MC, Franklyn JA 1997 Thyroid hormone and estrogen receptor expression in normal pituitary and nonfunctioning tumors of the anterior pituitary. J Clin Endocrinol Metab 82:1960-1967
28. Puzianowska-Kuznicka M, Nauman A, Madej A, Tanski Z, Cheng SY, Nauman J 2000 Expression of thyroid hormone receptors is disturbed in human renal clear cell carcinoma. Cancer Lett 155:145-152
29. Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G, Pierotti MA 1993 Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 91:1753-1760
30. Nikiforov YE, Nikiforova MN, Gnepp DR, Fagin JA 1996 Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene 13:687-693
31. Santoro M, Thomas GA, Vecchio G, Williams GH, Fusco A, Chiappetta G, Pozcharskaya V, Bogdanova TI, Demidchik EP, Cherstvoy ED, Voscoboinik L, Tronko ND, Carss A, Bunnell H, Tonnachera M, Parma J, Dumont JE, Keller G, Hofler H, Williams ED 2000 Gene rearrangement and Chernobyl related thyroid cancers. Br J Cancer 82:315-322
32. Holm R, Nesland JM 1994 Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland. J Pathol 72:267-272
33. Sugg SL, Ezzat S, Zheng L, Freeman JL, Rosen IB, Asa SL 1999 Oncogene profile of papillary thyroid carcinoma. Surgery 125:46-52
34. Zou M, Shi Y, Farid NR, al-Sedairy ST, Paterson MC 1999 FHIT gene abnormalities in both benign and malignant thyroid tumours. Eur J Cancer 35:467-472
35. Nikiforova MN, Stringer JR, Blough R, Medvedovic M, Fagin JA, Nikiforov YE 2000 Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 290:138-41
36. Kane FK, Langman MJS, Williams GR 1996 Antiproliferative responses of two human colon cancer cell lines to vitamin D are differentially modified by 9-cis retinoic acid. Cancer Res 56:623-632
37. Sakurai A, Nakai A, DeGroot LJ 1989 Expression of three forms of thyroid hormone receptor in human tissues. Mol Endocrinol. 3:392-399
38. Wells JA 1990 Additivity of mutational effects in proteins. Biochemistry 29:8509-8517
39. - symporter gene expression. Mol Endocrinol 12:727-736
40. - symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228-3234
41. Chen ST, Shieh HY, Lin JD, Chang KS, Lin KH 2000 Overexpression of thyroid hormone receptor β1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line. J Endocrinol 165:379-389
42. Bronnegard M, Torring O, Boos J, Sylven C, Marcus C, Wallin G 1994 Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue. J Clin Endocrinol Metab 79:384-389
43. Puzianowska-Kuznicka M, Shi YB 1996 Nuclear Factor I as a potential regulator during postembryonic organ development. J Biol Chem 271:6273-6282
44. Nakazato M, Chung KH, Ulianich L, Grassadonia A, Suzuki K, Kohn LD 2000 Thyroglobulin repression of thyroid transcription factor 1 (TTF-1) gene expression is mediated by decreased DNA binding of nuclear factor I proteins which control constitutive TTF-1 experssion. Mol Cell Biol 20:8499-8512
45. Ortiz L, Aza-Blanc P, Zannini M, Cato AC, Santisteban P 1999 The interaction between the forkhead thyroid transcription factor TTF-2 and the constitutive factor CTF/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription. J Biol Chem 274:15213-15221
46. Ros P, Rossi DL, Acebron A, Santisteban P 1999 Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Biochimie 81:389-396
47. Perez-Juste G, Garcia-Silva S, Aranda A 2000 An element in the region responsible for premature termination of transcription mediates repression of c-myc gene expression by thyroid hormone in neuroblastoma cells. J Biol Chem 275:1307-1314
48. Wallin G, Bronnegard M, Grimelius L, McGuire J, Torring O 1992 Expression of the thyroid hormone receptor, the oncogenes c-myc and H-ras, and the 90 kD heat shock protein in normal, hyperplastic, and neoplastic human thyroid tissue. Thyroid 2:307-313
49. Cerutti J, Trapasso F, Battaglia C, Zhang L, Martelli ML, Visconti R, Berlingieri MT, Fagin JA, Santoro M, Fusco A 1996 Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines. Clin Cancer Res 2:119-126
50. Zhang XK, Wills KN, Husmann M, Hermann T, Pfahl M 1991 Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities. Mol Cell Biol 11:6016-6025
51. Barrera-Hernandez G, Zhan Q, Wong R, Cheng SY 1998 Thyroid hormone receptor is a negative regulator in p53-mediated signaling pathways. DNA Cell Biol 17:743-750
52. Bhat MK, Yu CI, Yap N, Zhan Q, Hayashi Y, Seth P, Cheng S 1997 Tumor suppressor p53 is a negative regulator in thyroid hormone receptor pathways. J Biol Chem 272:28989-28993